A large observational study published in Nature Medicine by Cleveland Clinic researchers demonstrates that bariatric surgery delivers more substantial and sustained health benefits than GLP-1 receptor agonist treatments in individuals with obesity and type 2 diabetes. The data provides compelling evidence supporting the efficacy of surgical intervention over medical therapy alone, potentially influencing clinical practice guidelines for metabolic disease management.